Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine Bolus vs Infusion for Emergence Agitation in Nasal Surgery
NCT06867302Recruiting
- Sponsor
- Fayoum University Hospital
- Start
- Aug 2025
- Primary completion
- Nov 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of dexmedetomidine in Emergence agitation (EA) (2 arms), sponsored by Fayoum University Hospital. Primary endpoint: Richmond Agitation Sedation Scale. Started Aug 2025; status: recruiting.
02
Drugs
dexmedetomidine
03
Conditions
Emergence agitation (EA)
Beyond the preview
Go deeper on NCT06867302.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06867302.